Advances in Tumor Angiogenesis

Angiogenesis is the physiological process through which new blood vessels form from pre-existing vessels. Angiogenesis is a normal and vital process in growth and development, as well as in wound healing and in the formation of granulation tissue. However, it is also a fundamental step in the transition of tumors from a benign state to a malignant one, leading to the use of angiogenesis inhibitors in the treatment of cancer. Cancer cells are cells that have lost their ability to divide in a controlled fashion. A malignant tumor consists of a population of rapidly dividing and growing cancer cells that progressively accrues mutations. However, tumors need a dedicated blood supply to provide the oxygen and other essential nutrients they require in order to grow beyond a certain size. The essential role of angiogenesis in tumor growth was first proposed in 1971 by Judah Folkman, who described tumors as “hot and bloody.”

 

In the present book, fifteen typical literatures about tumor angiogenesis published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on medical science, angiology, oncology, epidemiology, ect. We hope this book can demonstrate advances in tumor angiogenesis as well as give references to the researchers, students and other related people.

Components of the Book:
  • Chapter 1
    The Role of Lymphangiogenesis and Angiogenesis in Tumor Metastasis
  • Chapter 2
    Proposal of a Hybrid Approach for Tumor Progression and Tumor-Induced Angiogenesis
  • Chapter 3
    Notch and VEGF Pathways Play Distinct but Complementary Roles in Tumor Angiogenesis
  • Chapter 4
    Complement and Macrophage Crosstalk during Process of Angiogenesis in Tumor Progression
  • Chapter 5
    Bidirectional Regulation of Angiogenesis and MiR-18a Expression by PNS in the Mouse Model of Tumor Complicated by Myocardial Ischemia
  • Chapter 6
    Blocking Heme Oxygenase-1 by Zinc Protoporphyrin Reduces Tumor Hypoxiamediated VEGF Release and Inhibits Tumor Angiogenesis as a Potential Therapeutic Agent against Colorectal Cancer
  • Chapter 7
    EGCG, A Major Green Tea Catechin Suppresses Breast Tumor Angiogenesis and Growth via Inhibiting the Activation of HIF-1α and NFκB, and VEGF Expression
  • Chapter 8
    Vasohibin-2 Modulates Tumor Onset in the Gastrointestinal Tract by Normalizing Tumor Angiogenesis
  • Chapter 9
    VEGF Is an Important Mediator of Tumor Angiogenesis in Malignant Lesions in a Genetically Engineered Mouse Model of Lung Adenocarcinoma
  • Chapter 10
    Erythropoietin Accelerates Tumor Growth through Increase of Erythropoietin Receptor (EpoR) as Well as by the Stimulation of Angiogenesis in DLD-1 and Ht-29 Xenografts
  • Chapter 11
    Lenvatinib, an Angiogenesis Inhibitor Targeting VEGFR/FGFR, Shows Broad Antitumor Activity in Human Tumor Xenograft Models Associated with Microvessel Density and Pericyte Coverage
  • Chapter 12
    MiR-126-3p Suppresses Tumor Metastasis and Angiogenesis of Hepatocellular Carcinoma by Targeting LRP6 and PIK3R2
  • Chapter 13
    Sunitinib Significantly Suppresses the Proliferation, Migration, Apoptosis Resistance, Tumor Angiogenesis and Growth of Triple-Negative Breast Cancers but Increases Breast Cancer Stem Cells
  • Chapter 14
    Spheroid-Plug Model as a Tool to Study Tumor Development, Angiogenesis, and Heterogeneity in Vivo
  • Chapter 15
    Cancer Anti‑Angiogenesis Vaccines: Is the Tumor Vasculature Antigenically Unique?
Readership: Students, academics, teachers and other people attending or interested in Tumor Angiogenesis
Roman Paduch
Department of Virology and Immunology, Institute of Microbiology and Biotechnology, Maria Curie-Sk?odowska University, Akademicka 19, Lublin, Poland

Darrell J. Yamashiro
Department of Pediatrics, Columbia University Medical Center, New York, NY, USA

Jian-Wei Gu
Cancer Institute, University of Mississippi Medical Center, Jackson, Mississippi, USA

Taichi Ezaki
Department of Anatomy and Developmental Biology, School of Medicine, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, Japan

Shusen Zheng
Department of Hepatobiliary Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Thomas E. Ichim
Batu Biologics Inc., Towne Center Drive, San Diego, CA, USA

and more...
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top